Back to calendar
Latigo Biotherapeutics, Inc. (LTGO) Earnings
LTGO reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.65
Actual EPS: $-0.52
Company overview
Market Cap$1.4B
PriceUSD 22.26
52-week high25.93
52-week low17.22
SectorHealth Technology
IndustryPharmaceuticals: Major